stars 1 stars 2 stars 3

LETIPharma, the Experimental Laboratory for Immunogenic Therapeutics, is an independent, family-owned, biopharmaceutical company. Since its creation, in 1919, LETIPharma has been working in immunotherapy based on the use of allergens, applying principals of personalized medicine, and a patient approach keeping with the “One Health” philosophy. LETIPharma integrates two lines of business, and several areas of work: HUMAN HEALTH - Immunology and Allergy, centered on the production of allergen extracts for allergy diagnosis and treatment. - Dermatology and skin care, which centers its activity on the development of dermo-pharmaceutical products as well as other special products designed for personal care and treatment of skin abnormalities. ANIMAL HEALTH A line specialized in producing solutions for Veterinary Immunology and Dermatology for the prevention, diagnosis and treatment of the major immune-mediated diseases found in pets, like allergy and leishmaniasis. LETIPharma is a Spanish multinational with solid international presence.

Laboratorios LETI Questions

The Laboratorios LETI annual revenue was $9.1 million in 2026.

Fabio Ferraro is the CTO of Laboratorios LETI.

332 people are employed at Laboratorios LETI.

Laboratorios LETI is based in Barcelona, Catalonia.

The NAICS codes for Laboratorios LETI are [3254, 32, 32541, 325].

The SIC codes for Laboratorios LETI are [283, 2834, 28].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Spring 2026 G2 Best Est ROI Mid Market Spring 2026 G2 Easiest Admin Mid Market Spring 2026 G2 Most Implementable Spring 2026 G2 Best Results Mid Market Spring 2026 G2 Lead Capture Mid Market Spring 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users